MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2022-23)
- Udyam number
- UDYAM-TS-02-0000073
VKT Pharma Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹31.93 Cr
▼ 20% YoY
Net loss · FY 2023
₹29.94 Cr
Net margin -93.8%
EBITDA · FY 2023
-₹22.42 Cr
EBITDA margin -70.2%
Authorised capital
₹12 Cr
Registered with MCA
Paid-up capital
₹11.06 Cr
Issued & subscribed
Open charges
₹340 Cr
Satisfied ₹355.79 Cr
Company age
20 yrs
Est. 2006
Employees · EPFO
238
Provident fund records
About VKT Pharma Private Limited
Data last updated:
VKT Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 31 May 2006 and has been in existence for over 20 years.
Its director Ramesh Babu Potluri and family are #1,090 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG2006PTC050221. Its GSTIN is 36AAECP4284E1ZE (Telangana). The company holds 3 GST registrations, all of them active.
The company has an authorised share capital of ₹12 Cr and a paid-up capital of ₹11.06 Cr. It was formerly known as Potluri Builders Private Limited. It is led by directors including Vamsi Krishna Potluri (Managing Director) and Ramesh Babu Potluri.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2023, the company reported a revenue of ₹31.93 Cr, a decline of 20% compared to the previous year. For the same year it recorded a net loss of ₹29.94 Cr (net margin -93.8%) and EBITDA of -₹22.42 Cr (EBITDA margin -70.2%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 42% over five years.
The company has about 238 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: VKT Pharma. As per MCA filings, the company has open charges of ₹340 Cr and satisfied charges of ₹355.79 Cr on record. Court records list 10 cases involving the company, including 8 filed by the company and 2 filed against it. The company has 25 deals on record (17 secondary share transfers, 7 funding rounds, 1 rights issue), with disclosed funding of ₹122.94 Cr; the latest was in March 2024. Its 5 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 3 smaller; the largest is Skymap Healthcare Private Limited with revenue of ₹65.96 Cr.
VKT Pharma Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0000073). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vktpharma.com.
Company details
CIN U24100TG2006PTC050221
Registration Number 050221
Incorporation Date 31 May 2006
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-TS-02-0000073
CIN history
VKT Pharma has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24100TG2006PTC050221, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24100TG2006PTC050221 | Current |
| U24100AP2006PTC050221 | Previous |
| U45201AP2006PTC050221 | Previous |
Key People
Vamsi Krishna Potluri Managing Director Ramesh Babu Potluri Director Hima Bindu Potluri Director Recognitions & Rankings of VKT Pharma
India's Richest People 2026 edition · 1 director · Source: Hurun India
- #1,090 Ramesh Babu Potluri & family ₹2,400 Cr
Contact details
VKT Pharma Private Limited's registered office is in Hyderabad, Telangana. Its website is vktpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No. 72 H.No: 8 – 2 – 334/3&4 Road No. 5 Opp. Sbi Executive Enclave Banjara Hill, S, Hyderabad, Telangana, India – 500034
- IndustryPharma, Drug Formulation & Development
To see the full contact details of VKT Pharma Private Limited, buy the company report.
Comprehensive company report
VKT Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
VKT Pharma operates one associated brand: VKT Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Develops and manufactures generic pharmaceutical products with R&D and global partnerships. | vktpharma.com |
Business activity
The main business activity of VKT Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of VKT Pharma Private Limited, buy the company report.
Financials of VKT Pharma Private Limited
FY 2025 filings availableVKT Pharma Private Limited reported revenue of ₹31.93 Cr (down 20% YoY) for FY 2023.
Revenue · FY 2023
₹31.93 Cr ▼ 20%
Net loss · FY 2023
₹29.94 Cr margin -93.8%
EBITDA · FY 2023
-₹22.42 Cr margin -70.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 20%
3 years · compounded
▼ 6%
5 years · compounded
▲ 42%
Revenue fell 20% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 42%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹31.93 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹22.42 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹29.94 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -70.2% | ||||
| Net Profit Margin | -93.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of VKT Pharma Private Limited, buy the company report.
Board of directors of VKT Pharma Private Limited
VKT Pharma has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ramesh Babu Potluri Also directs: Potluri Agri Farms LLP, SMS Pharmaceuticals Limited, SMS Peptides Private Limited and 1 more | Director | 31 May 2006 | 20 Years 4 Months | Current |
| Hima Bindu Potluri Also directs: Potluri Agri Farms LLP | Director | 31 May 2006 | 20 Years 4 Months | Current |
| Vamsi Krishna Potluri Also directs: SMS Pharmaceuticals Limited, SMS Peptides Private Limited, Potluri Infra Projects LLP and 3 more | Managing Director | 16 Aug 2014 | 12 Years 2 Months | Current |
Peer comparison
VKT Pharma Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Skymap Healthcare Private Limited | ₹65.96 Cr (FY 2022) | 70.0% | New Delhi, Delhi, India | |||
| Caplet India Pvt.Ltd. | ₹65.86 Cr (FY 2025) | -5.0% | Kolkata, West Bengal, India | |||
| Celebrity Biopharma Limited | ₹65.65 Cr (FY 2024) | -33.0% | Himachal Pradesh, India | |||
| Man Care Laboratories Private Limited | ₹65.62 Cr (FY 2025) | 31.0% | Ranchi, Jharkhand, India | |||
| Storks Medi-Tek Private Limited | ₹65.43 Cr (FY 2025) | 36.0% | Ahmedabad, Gujarat, India | |||
| VKT Pharma Private Limitedthis company | ₹31.93 Cr (FY 2023) | -₹29.94 Cr | -93.8% | -20.0% | 238 | Hyderabad, Telangana, India |
To see the full peer comparison of VKT Pharma Private Limited, buy the company report.
Auditor
VKT Pharma Private Limited is audited by ADUSUMILLI & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ADUSUMILLI & ASSOCIATES | FY 2023 | 006983S |
Shareholding
The shareholding of VKT Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of VKT Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹340 Cr
Satisfied charges
₹355.79 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Nov 2025 | 101195770 | Others | ₹20 Cr | Open | |
| 20 Nov 2025 | 101187310 | Others | ₹150 Cr | Open | |
| 13 Oct 2025 | 101167656 | Others | ₹150 Cr | Open | |
| 26 Sep 2024 | 100987403 | Others | ₹20 Cr | Open | |
| 02 Nov 2023 | 100826853 | Others | ₹130 Cr | Satisfied |
To see the full charge records of VKT Pharma Private Limited, buy the company report.
Total charge records: 10 View all charges
Deals & funding
VKT Pharma Private Limited has 25 deals on record (17 secondary share transfers, 7 funding rounds, 1 rights issue), with disclosed funding of ₹122.94 Cr; the latest was in March 2024.
Total deals
25
Secondary share transfers
17
Funding rounds
7
Rights issue
1
Disclosed funding
₹122.94 Cr
Deals on record (5 of 25)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2024 | Secondary share transfer | Undisclosed | Buyer: Saava Ventures LLP , an individual Seller: 3 individuals |
| May 2023 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: Bhawani Freight & Forwarder Private Limited |
| Mar 2023 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: GCB Finvest P Ltd. , Ideal Buildcon Pvt Ltd , PNC Capital Trust Ltd |
| Mar 2022 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: Ardhi Vanijya Pvt Ltd , an individual |
| Jan 2022 | Funding round | ₹39 Cr | Investors: Kakinada Infrastructure Holdings Private Limited , United Portservices Private Limited |
To see the full deal history of VKT Pharma Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
VKT Pharma Private Limited has 10 court cases on record: 8 filed by VKT Pharma, 2 filed against it. All cases are disposed.
Total cases
10
Filed by the company
8
Filed against the company
2
Disposed
10
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 10 | 2 | 0 |
Cases on record (5 of 10)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Thane, Maharashtra | Court case (Sum.Civ.Suit) | Filed against the company by M/S. Parle Elizabeth Tools Pvt Ltd., | Disposed |
| District court, Hyderabad CCC, Telangana | Criminal complaint | Filed by the company against Ms. Goldfish Pharma Pvt. Ltd. | Disposed |
| District court, Hyderabad Central, Telangana | Civil suit | Filed by the company against M/S. Achiever Pharmatech and 1 other | Disposed |
| District court, Hyderabad Central, Telangana | Civil suit | Filed by the company against M/S. Divine Pharmaceuticals and 1 other | Disposed |
| District court, Hyderabad Central, Telangana | Court case (STC- NI) | Filed by the company against M/S. Divine Pharmaceuticals Rep. by Mr. Kamlesh Patel and 1 other | Disposed |
To see the full case history of VKT Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
VKT Pharma Private Limited was last rated by Care on 03 Sep 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Care | 03 Sep 2021 |
To see the full credit ratings and regulatory alerts of VKT Pharma Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for VKT Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
VKT Pharma Private Limited has a workforce of 238 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.
Employee count
238
Active EPFO establishments
1
Employee growth
14.98%
GST
VKT Pharma has 3 GST registrations: 3 active.
Total GSTINs
3
Active
3
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAECP4284E1ZE | Telangana | Active | 01 Jul 2017 |
| 36AAECP4284E2ZD | Telangana | Active | 31 Aug 2023 |
| 37AAECP4284E1ZC | Andhra Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of VKT Pharma Private Limited, buy the company report.
Recent activity
VKT Pharma Private Limited has 7 board changes on record since 2006: 5 appointments and 2 cessations. The latest: Venkatasubbarao Potluri ceased to be Director on 12 Dec 2022.
Charges
A charge with Others amounted to Rs. 20.00 Cr with Charge ID 101195770 was registered on 20 Nov 2025.
Charges
A charge with Others amounted to Rs. 150.00 Cr with Charge ID 101187310 was registered on 20 Nov 2025.
Charges
A charge registered on 02 Nov 2023 via Charge ID 100826853 with Others was fully satisfied on 28 Oct 2025.
Charges
A charge with Others amounted to Rs. 150.00 Cr with Charge ID 101167656 was registered on 13 Oct 2025.
AGM
Vkt Pharma Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Charges
A charge with Others of Rs. 20.00 Cr registered on 26 Sep 2024 with Charge ID 100987403 was modified on 18 Jun 2025.
Filing
Vkt Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Others amounted to Rs. 20.00 Cr with Charge ID 100987403 was registered on 26 Sep 2024.
Charges
A charge with Others of Rs. 130.00 Cr registered on 02 Nov 2023 with Charge ID 100826853 was modified on 18 Apr 2024.
Charges
A charge registered on 13 Jun 2017 via Charge ID 100112216 with Others was fully satisfied on 08 Dec 2023.
Charges
A charge with Others amounted to Rs. 130.00 Cr with Charge ID 100826853 was registered on 02 Nov 2023.
Ceased
Venkatasubbarao Potluri ceased to be Director.
21 earlier events are in the company report.
Frequently asked questions
VKT Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 31 May 2006 (20+ years old) and is registered under CIN U24100TG2006PTC050221.
VKT Pharma has 3 current directors:
- Vamsi Krishna Potluri - Managing Director
- Ramesh Babu Potluri - Director
- Hima Bindu Potluri - Director
The latest financial statements of VKT Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of VKT Pharma is 36AAECP4284E1ZE, registered in Telangana. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 36AAECP4284E2ZD (Telangana), 37AAECP4284E1ZC (Andhra Pradesh).
The CIN (Corporate Identification Number) of VKT Pharma is U24100TG2006PTC050221. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
VKT Pharma has 10 court cases on record: 8 filed by the company and 2 filed against it.
VKT Pharma was incorporated on 31 May 2006, making it 20+ years old. It is registered with the Registrar of Companies, Hyderabad.
VKT Pharma has 25 deals on record (17 secondary share transfers, 7 funding rounds, 1 rights issue), with disclosed funding of ₹122.94 Cr; the latest was in March 2024.
The peers of VKT Pharma by revenue are Skymap Healthcare Private Limited, Caplet India Pvt.Ltd, Celebrity Biopharma Limited, Man Care Laboratories Private Limited, Storks Medi-Tek Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Venkatasubbarao Potluri ceased to be Director on 12 Dec 2022. Subramanyeswara Rao Kudaravalli ceased to be Additional Director on 29 Nov 2015. Subramanyeswara Rao Kudaravalli was appointed as Additional Director on 06 Dec 2014. VKT Pharma has 7 board changes on record in total.
Yes, VKT Pharma is registered as a medium enterprise under Udyam registration (number: UDYAM-TS-02-0000073).